A Bayesian Hybrid Design with Borrowing from Historical Study
Zhaohua Lu, John Toso, Girma Ayele, Philip He

TL;DR
This paper introduces a Bayesian hybrid design for early phase drug combination trials that leverages historical data to improve decision-making and study efficiency, with a flexible and computationally efficient framework.
Contribution
It develops a Bayesian dynamic power prior framework for controlled information borrowing in hybrid trial designs, enhancing flexibility and interpretability.
Findings
Improved power in detecting drug activity compared to traditional designs
Closed-form posterior distribution for computational efficiency
Validated through simulations and a case study
Abstract
In early phase drug development of combination therapy, the primary objective is to preliminarily assess whether there is additive activity from a novel agent when combined with an established monotherapy. Due to potential feasibility issues for conducting a large randomized study, uncontrolled single-arm trials have been the mainstream approach in cancer clinical trials. However, such trials often present significant challenges in deciding whether to proceed to the next phase of development due to the lack of randomization in traditional two-arm trials. A hybrid design, leveraging data from a completed historical clinical study of the monotherapy, offers a valuable option to enhance study efficiency and improve informed decision-making. Compared to traditional single-arm designs, the hybrid design may significantly enhance power by borrowing external information, enabling a more robust…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOptimal Experimental Design Methods
